REdI Conference
The Regulatory Education for Industry (REdI) Program is a free FDA-led conference that brings together the regulatory educators from the FDA's medical product centers: Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH), and Center for Biologics Evaluation and Research (CBER).
Goal:
To educate the regulatory community with current information about FDA’s regulation of drugs, devices, and biologics.
Audience:
Small manufacturers, researchers, and innovators seeking to learn about how the FDA regulates drugs, devices, and biologics medical products.
Program Series and Format:
- The conference is offered in a hybrid format, with both virtual and in-person presentations.
- For each FDA medical product center, REdI features a plenary session that combines the themes of drugs (CDER), devices (CDRH), and biologics (CBER) regulatory policy.
- Topics span total product lifecycle.
REdI 2024
REdI 2024 was held on May 29-30, 2024, with well over 20,000 online and in-person attendees! Recordings of the 13 CDRH sessions are available here:
You may access individual topics by selecting the chapter.